Search This Blog

Wednesday, January 28, 2026

Morgan Stanley upgrades Johnson & Johnson, sees upside on robust drug pipeline

 Johnson & Johnson (JNJ) stock gains as Morgan Stanley upgrades the company to Overweight, lifting the price target to $262

https://seekingalpha.com/news/4543639-jj-upgraded-morgan-stanley-growth-outlook

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.